Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma
Non-melanoma skin cancer (NMSC) includes a wide range of cutaneous tumors, the most frequent of which are basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (CSCC). Although NMSC is usually cured by surgical resection, in rare cases it can progress to locally advanced and metastatic di...
Saved in:
| Main Authors: | Dirk Schadendorf, Paolo A Ascierto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-12-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/10/12/e005082.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative Analysis of US Guidelines for the Management of Cutaneous Squamous Cell and Basal Cell Carcinoma
by: Amit Mittal, et al.
Published: (2024-01-01) -
Development of diffuse cutaneous squamous cell carcinoma in situ after chemotherapy for ovarian carcinoma and remission with PD1-inhibitor
by: Jess Durbin, et al.
Published: (2024-12-01) -
Differential Expression Analysis of Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma Proteomic Profiles Sampled with Electroporation-Based Biopsy
by: Edward Vitkin, et al.
Published: (2024-11-01) -
IL-17 mediates angiogenesis in Basal Cell Carcinomas and Squamous Cell Carcinomas
by: D. Cunha, et al.
Published: (2024-01-01) -
Skin squamous cell carcinoma or Cutaneous Leishmaniasis? Case report and review of the literature
by: Resi Pucci, et al.
Published: (2023-09-01)